The earnings call reflects both the challenges and progress P3 Health Partners is experiencing. While there are significant improvements in operational performance and strategic initiatives, financial metrics like EBITDA and membership decline present ongoing challenges. The company is on a positive trajectory with long-term strategies potentially yielding further gains, yet near-term financial hurdles remain.

Company Guidance

During the P3 Health Partners Second Quarter 2025 Earnings Conference Call, the company provided guidance on its financial performance and strategic initiatives. P3 is nearing the execution of a $130 million EBITDA improvement plan, with three out of four markets reaching breakeven or better for the first half of 2025. The company reported a membership of 115,000, aligning with expectations, and an adjusted EBITDA loss of $17 million for the quarter. Excluding prior period adjustments of $9 million, the normalized loss was $8 million, reflecting a $5 million improvement from Q1. P3 is revising its full-year guidance to an adjusted EBITDA loss range of $39 million to $69 million, considering prior period headwinds and noncore asset performance. For 2026, the company anticipates driving additional EBITDA improvements of $120 million to $170 million, with key opportunities identified in operational enhancements, contract renegotiations, and benefit design adjustments. The company has also seen improvements in medical cost trends, achieving a year-over-year funding increase of 10% on a normalized per member basis, and continues to expand its network and clinical programs, positioning itself for profitability in 2026 and beyond.

EBITDA Improvement Plan Execution

P3 Health Partners is nearing full execution of their $130 million EBITDA improvement plan, indicating positive movement in their core business and positioning for continued momentum into 2026.

Contractual Improvements

Successfully renegotiated a contract with a major payer, positioning the company to achieve approximately $20 million in improvements. Also, a contract amendment and extension of senior debt is nearing finalization.

Operational Performance and Cost Management

Medical cost trends remained materially flat year-over-year, showcasing effective cost management. Funding improved by 10% across membership on a normalized basis, reflecting gains in operational execution.

Expansion and Growth Pipeline

Growth pipeline exceeds 35,000 members, with a strategic joint venture anticipated to add 13,000 to 14,000 fully accretive lives.

Clinical Program Success

The care enablement model launched last year is delivering accelerated results, including almost 3x improvement in care gap closures and significant reductions in medical expenses through improved hospice and palliative care programs.

P3 Health Partners (PIII) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PIII Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q3)	-5.71 / -	-15.5	―	―	―
Aug 14, 2025	2025 (Q2)	-5.86 / -6.23	-7.5	16.93% (+1.27)	―
May 15, 2025	2025 (Q1)	-8.16 / -6.28	-8	21.50% (+1.72)	―
Mar 27, 2025	2024 (Q4)	-4.09 / -18.00	-11	-63.64% (-7.00)	―
Nov 12, 2024	2024 (Q3)	-1.84 / -15.50	-6	-158.33% (-9.50)	―
Aug 07, 2024	2024 (Q2)	-2.20 / -7.50	-4.5	-66.67% (-3.00)	―
May 08, 2024	2024 (Q1)	-6.36 / -8.00	-11	27.27% (+3.00)	―
Mar 28, 2024	2023 (Q4)	-5.48 / -11.00	-113	90.27% (+102.00)	―
Nov 08, 2023	2023 (Q3)	-8.97 / -6.00	-13.5	55.56% (+7.50)	―
Aug 07, 2023	2023 (Q2)	-6.50 / -4.50	-186.5	97.59% (+182.00)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PIII Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	$6.94	$6.78	-2.31%
May 15, 2025	$8.30	$7.99	-3.73%
Mar 27, 2025	$9.04	$8.62	-4.65%
Nov 12, 2024	$19.52	$12.50	-35.96%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does P3 Health Partners (PIII) report earnings?

P3 Health Partners (PIII) is schdueled to report earning on Nov 18, 2025, After Close (Confirmed).

What is P3 Health Partners (PIII) earnings time?

P3 Health Partners (PIII) earnings time is at Nov 18, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is PIII EPS forecast?

PIII EPS forecast for the fiscal quarter 2025 (Q3) is -5.71.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing